FDA Stance on CBD Requires Congress to Intervene

摘要

The U.S. FDA’s rejection of two New Dietary Ingredient Notifications for full-spectrum hemp extracts (FSHE) containing cannabidiol (CBD)—submitted by Charlotte’s Web and Irwin Naturals—effectively means it’s up to Congress to clarify what it intended with the passage of the 2018 Farm Bill.